Android app on Google Play

RBC Capital Starts Salix Pharmaceuticals (SLXP) at Outperform

January 11, 2013 7:17 AM EST Send to a Friend
Get Alerts SLXP Hot Sheet
Price: $100.66 +2.52%

Rating Summary:
    15 Buy, 9 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 34 | Down: 12 | New: 36
Trade SLXP Now!
Join SI Premium – FREE
RBC Capital initiates coverage on Salix Pharmaceuticals (NASDAQ: SLXP) with a Outperform. PT $53.00.

For an analyst ratings summary and ratings history on Salix Pharmaceuticals click here. For more ratings news on Salix Pharmaceuticals click here.

Shares of Salix Pharmaceuticals closed at $45.59 yesterday.

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

RBC Capital

Add Your Comment